These included, among others, VEGF—known to promote ovarian cancer neovascularization [22], TGF-β1—recognized as a mediator of EMT [23] and increased ovarian cancer cell invasion [24], proinflammatory and ovarian cancer cell growth-promoting IL-6 [25], and pro-migratory HGF [26]. This evidence concerns the gene TGFB1 and ovarian cancer.